Evidence map›Paper›PMID 39851471›Full record

ArticleDiseases (Basel, Switzerland)2025

Advanced Glycation End-Product-Modified Heat Shock Protein 90 May Be Associated with Urinary Stones.

Takanobu Takata, Shinya Inoue, Kenshiro Kunii, Togen Masauji, Junji Moriya, Yoshiharu Motoo, Katsuhito Miyazawa

Abstract read
In one paragraph

Article in Diseases (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Potential of Orally Administered Quercetin, Hesperidin, andInternational journal of molecular sciences · 2025
    Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Takanobu TakataDivision of Molecular and Genetic Biology, Department of Life Science, Medical Research Institute, Kanazawa Medical University, Uchinada 920-0293, Ishikawa, Japan.ORCID 0000-0003-0514-8584
Shinya InoueDepartment of Urology, Kanazawa Medical University, Uchinada 920-0293, Ishikawa, Japan.ORCID 0000-0001-8639-6955
Kenshiro KuniiDepartment of Urology, Kanazawa Medical University, Uchinada 920-0293, Ishikawa, Japan.
Togen MasaujiDepartment of Pharmacy, Kanazawa Medical University Hospital, Uchinada 920-0293, Ishikawa, Japan.ORCID 0009-0000-5897-8800
Junji MoriyaDepartment of General Internal Medicine, Kanazawa Medical University, Uchinada 920-0293, Ishikawa, Japan.
Yoshiharu MotooDepartment of Internal Medicine, Fukui Saiseikai Hospital, Wadanaka 918-8503, Fukui, Japan.
Katsuhito MiyazawaDepartment of Urology, Kanazawa Medical University, Uchinada 920-0293, Ishikawa, Japan.ORCID 0000-0002-0331-3753

Funding

Japan Society for the Promotion of Science JP22K16798Japan Society for the Promotion of Science JP24K14802
6 · The paper itself

Abstract

backgroundUrinary stones (urolithiasis) have been categorized as kidney stones (renal calculus), ureteric stones (ureteral calculus and ureterolith), bladder stones (bladder calculus), and urethral stones (urethral calculus); however, the mechanisms underlying their promotion and related injuries in glomerular and tubular cells remain unclear. Although lifestyle-related diseases (LSRDs) such as hyperglycemia, type 2 diabetic mellitus, non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, and cardiovascular disease are risk factors for urolithiasis, the underlying mechanisms remain unclear. Recently, heat shock protein 90 (HSP90) on the membrane of HK-2 human proximal tubular epithelium cells has been associated with the adhesion of urinary stones and cytotoxicity. Further, HSP90 in human pancreatic and breast cells can be modified by various advanced glycation end-products (AGEs), thus affecting their function. Hypothesis 1: We hypothesized that HSP90s on/in human proximal tubular epithelium cells can be modified by various types of AGEs, and that they may affect their functions and it may be a key to reveal that LSRDs are associated with urolithiasis. Hypothesis 2: We considered the possibility that Japanese traditional medicines for urolithiasis may inhibit AGE generation. Of Choreito and Urocalun (the extract of

Indexed as

advanced glycation end-productsargpyrimidineGLAPheat shock protein 90lifestyle-related diseaseMG-H1quercetintraditional Japanese medicineureteric stoneurocalun

Identifiers

PMID39851471
PMCPMC11764404

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.